KEY PRODUCTS
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
01 1DIFLUNISAL USP
01 1India
01 1Active
01 1Blank
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34818
Submission : 2020-04-20
Status : Active
Type : II
20
Cohance Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
One of their notable products is DIFLUNISAL USP, with a corresponding US DMF Number 34818.
Remarkably, this DMF maintains an Active status since its submission on April 20, 2020, highlighting commitment to regulatory compliance.
